Spectacle Lenses With Highly Aspherical Lenslets for Slowing Myopia: A Randomized, Double-Blind, Cross-Over Clinical Trial

被引:10
|
作者
Sankaridurg, Padmaja [1 ,2 ]
Weng, Rebecca [1 ]
Tran, Huy [1 ]
Spiegel, Daniel P. [3 ]
Drobe, Bjorn [3 ]
Thao Ha [4 ]
Tran, Yen H. [4 ]
Naduvilath, Thomas [1 ,2 ]
机构
[1] Brien Holden Vis Inst BHVI, Sydney, NSW, Australia
[2] Univ New South Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia
[3] Essilor R&D Ctr Singapore, Singapore, Singapore
[4] Haiyen Eye Care, Ho Chi Minh City, Vietnam
关键词
PROGRESSION;
D O I
10.1016/j.ajo.2022.10.021
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To evaluate myopia progression with highly aspherical lenslet (HAL) spectacles vs conventional single vision (SV) spectacles. DESIGN: Prospective, double-blind, single-center, randomized, cross-over trial. METHOD: A total of 119 Vietnamese children (7-13 years of age, spherical equivalent refractive error [SE] = 0.75 to -4.75D) were randomized to wear either HAL or SV, and after 6 months (stage 1) crossed over to the other lens for another 6 months (stage 2). At the end of stage 2, both groups wore HAL for a further 6 months. In the order that lenses were worn at each stage, group 1 was designated HSH (HAL-SV-HAL) and group 2 SHH (SVHAL-HAL). The main outcome measures were a comparison between HAL and SV for change ( Delta) in SE and axial length (AL) during each stage; and a comparison of Delta SE/AL with SV between HSH and SHH groups to determine whether myopia rebounded when switched from HAL to SV (HSH group). RESULTS: Myopia progressed more slowly with HAL than with SV during stages 1 and 2 (SE Delta stage 1: -0.21 vs -0.27D, P =.317, stage 2: -0.05 vs -0.32D, P <.001; AL Delta stage 1: 0.07 vs 0.14 mm, P =.004; stage 2: 0.04 vs 0.17 mm, P <.001). Delta SE/AL with SV was not different between the HSH and SHH groups ( Delta SE -0.33 +/- 0.27D vs -0.27 +/- 0.42D, P =.208; Delta AL 0.17 +/- 0.13mm vs 0.13 +/- 0.15 mm, P =.092). An average of 14 hours per day of lens wear was reported with both lenses. CONCLUSIONS: In this cross-over trial, intergroup and intragroup comparisons indicate that HAL slows myopia. Children were compliant with lens wear, and data were not suggestive of rebound when patients were switched from HAL to SV. (Am J Ophthalmol 2023;247: 18-
引用
收藏
页码:18 / 24
页数:7
相关论文
共 50 条
  • [31] Clinical effects of purified air administered to the breathing zone in allergic asthma: A double-blind randomized cross-over trial
    Pedroletti, C.
    Millinger, E.
    Dahlen, B.
    Soderman, P.
    Zetterstrom, O.
    [J]. RESPIRATORY MEDICINE, 2009, 103 (09) : 1313 - 1319
  • [32] Effects of deep transcranial magnetic stimulation of the cerebellum on cerebellar ataxias: A randomized, double-blind, cross-over clinical trial
    Franca, C.
    de Andrade, D.
    Silva, V.
    Galhardoni, R.
    Barbosa, E.
    Teixeira, M.
    Cury, R.
    [J]. MOVEMENT DISORDERS, 2020, 35 : S13 - S13
  • [33] A DOUBLE-BLIND CROSS-OVER TRIAL OF AMANTADINE HYDROCHLORIDE IN FRIEDREICHS ATAXIA
    FILLA, A
    DEMICHELE, G
    OREFICE, G
    SANTORELLI, F
    TROMBETTA, L
    BANFI, S
    SQUITIERI, F
    NAPOLITANO, G
    PUMA, D
    CAMPANELLA, G
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1993, 20 (01) : 52 - 55
  • [34] DOUBLE-BLIND CROSS-OVER TRIAL OF TRIMETHOPRIM AND SULPHAMETHOXAZOLE IN CHRONIC BRONCHITIS
    WEBSTER, IW
    [J]. THORAX, 1971, 26 (03) : 319 - +
  • [35] The Effect of Rosa Damascena Extract on Primary Dysmenorrhea: A Double-blind Cross-over Clinical Trial
    Bani, Soheila
    Hasanpour, Shirin
    Mousavi, Zeinabalsadat
    Garehbaghi, Parvin Mostafa
    Gojazadeh, Morteza
    [J]. IRANIAN RED CRESCENT MEDICAL JOURNAL, 2014, 16 (01)
  • [36] A randomized, double-blind, cross-over trial investigating the effect of liraglutide on the absorption of an oral contraceptive drug
    Jacobsen, Lisbeth V.
    Brondsted, Lise
    Vouis, Jan
    Zdravkovic, Milan
    [J]. DIABETES, 2008, 57 : A566 - A566
  • [37] Safety and tolerability of virucidal hand rubs: a randomized, double-blind, cross-over trial with healthy volunteers
    Andreas Conrad
    Birgit Grotejohann
    Claudia Schmoor
    Drago Cosic
    Markus Dettenkofer
    [J]. Antimicrobial Resistance and Infection Control, 4
  • [38] Improvement of Seminal Parameters with Prelox®: A Randomized, Double-blind, Placebo-controlled, Cross-over Trial
    Stanislavov, R.
    Nikolova, V.
    Rohdewald, P.
    [J]. PHYTOTHERAPY RESEARCH, 2009, 23 (03) : 297 - 302
  • [39] Safety and tolerability of virucidal hand rubs: a randomized, double-blind, cross-over trial with healthy volunteers
    Conrad, Andreas
    Grotejohann, Birgit
    Schmoor, Claudia
    Cosic, Drago
    Dettenkofer, Markus
    [J]. ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2015, 4
  • [40] A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, CROSS-OVER, CLINICAL-TRIAL OF Q-FEVER VACCINE IN SELECTED QUEENSLAND ABATTOIRS
    SHAPIRO, RA
    SISKIND, V
    SCHOFIELD, FD
    STALLMAN, N
    WORSWICK, DA
    MARMION, BP
    [J]. EPIDEMIOLOGY AND INFECTION, 1990, 104 (02): : 267 - 273